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Abstract
Objective-To examine whether impaired glucose tolerance and raised Lp(a) lipoprotein concentrations are associated in subjects with coronary artery disease.
Design-Study of two subject populations, one with and one without symptomatic coronary artery disease. Case-control analysis of patients with impaired glucose tolerance and normal glucose tolerance performed in each subject population independently.
Setting-A general practice and a hospital ward in Newcastle upon Tyne.
Subjects-517 apparently healthy subjects, 13 with impaired glucose tolerance, and 245 patients who had undergone coronary artery bypass graft surgery 12 months before, 51 with impaired glucose tolerance.
Main outcome measures-Serum Lp(a) lipoprotein concentration, plasma glucose concentration before and after oral challenge with 75 g glucose monohydrate, and Lp(a) lipoprotein isoforms.
Results-In both the asymptomatic subjects and the subjects with coronary artery disease there was no significant difference between subjects with impaired glucose tolerance and subjects with normal glucose tolerance who were matched for age, sex, and body mass index in serum Lp(a) lipoprotein concentrations (geometric mean 61 (geometric SD 4) mg/l v 83 (5) mg/l for asymptomatic subjects, 175 (3) v 197 (2) for subjects with heart disease), nor was there any difference in the proportion of subjects who had Lp(a) lipoprotein concentrations > 300 mg/l (31% v 23% for asymptomatic subjects, 37% v 37% for subjects with heart disease). For both subject groups there was no significant correlation between Lp(a) lipoprotein concentration and plasma glucose concentration after a glucose tolerance test, nor did Lp(a) lipoprotein concentration vary by quintile of glucose concentration after the test. Examination of Lp(a) lipoprotein isoforms in the subjects with coronary artery disease revealed an inverse relation between isoform size and plasma Lp(a) lipoprotein concentration, but there was no evidence that impaired glucose tolerance was associated with particular Lp(a) lipoprotein isoforms.
Conclusion-Raised Lp(a) lipoprotein concentrations are not responsible for the association between impaired glucose tolerance and coronary artery disease.
Introduction
Impaired glucose tolerance has been associated with an approximate doubling in the risk of ischaemic heart disease in studies performed in the United Kingdom.' 2 High circulating Lp(a) lipoprotein concentrations have also been associated with an increased risk of ischaemic heart disease.-" A study of people with no evidence of ischaemic heart disease suggested a fivefold increase in the prevalence of raised lipoprotein(a) concentrations (> 300 mg/l) in those with impaired glucose tolerance compared with those with normal glucose tolerance. '4 It was proposed that a high concentration of lipoprotein(a) may explain the inpreased risk of ischaemic heart disease in people with impaired glucose tolerance. To investigate this we examined the relation between glucose tolerance and circulating lipoprotein(a) concentrations in normal subjects and patients with severe coronary artery disease. We also examined the relation between lipoprotein(a) isoform (a determinant of total concentration" '8) Venous blood samples were taken for various analyses from the subjects after they had fasted overnight for [10] [11] [12] hours. The subjects were given a drink containing 75 g glucose monohydrate, and another blood sample was taken two hours later (10) 77 (10) 76 (10) 76 (10) Serum concentrations (mmolll): to measure glucose concentration. Venous plasma glucose concentrations were measured by an automated glucose oxidase assay (interassay coefficient of variation 1-3% Table I shows the characteristics of the subjects selected for study and those of the cohorts from which they were recruited. Of the 524 asymptomatic, apparently normal subjects initially chosen, five had diabetes mellitus and were not considered further. Of the 263 subjects with coronary artery disease initially selected, 18 had diabetic tolerance tests and were not considered further. The values given for the subjects with heart disease are from preoperative measurements taken before the subjects underwent coronary artery bypass surgery. The subjects studied were representative oftheir respective cohorts. ASYMPTOMATIC 
SUBJECTS
Of the 519 subjects studied, 15 showed impaired glucose tolerance and 13 of these were matched with BMJ VOLUME 307 2 OCTOBER1993 833 26 subjects with normal glucose tolerance (table II) . The subjects with impaired glucose tolerance were significantly older than the 504 subjects with normal glucose tolerance and had higher body mass index, systolic and diastolic blood pressures, and serum triglyceride concentration. There was, however, no significant difference in the serum concentrations of Lp(a) lipoprotein, the proportion of subjects with high Lp(a) lipoprotein concentrations (> 300 mg/I), and the concentrations of serum cholesterol and plasma high density lipoprotein cholesterol. There was no difference between the subjects with impaired glucose tolerance and their matched controls except for plasma glucose concentrations.
In the group as a whole there was no significant correlation between the log of the circulating Lp(a) lipoprotein concentration and the plasma glucose concentration two hours after oral challenge with glucose (log Lp(a) lipoprotein concentration=0-008 plasma glucose concentration+1 87, r2=0 001, p= 0 56). There was, however, a significant positive correlation between glucose tolerance and serum triglyceride concentration (log triglyceride concentration=0-027 plasma glucose concentration -0 04, r= 0-061, p < 0 0001) and a significant negative correlation between glucose tolerance and high density lipoprotein cholesterol concentration (concentration= -0-025 plasma glucose concentration+ 1-54, r2=0 017, p < 0 0 1). Concentrations of Lp(a) lipoprotein were no different in the subjects in the lowest quintile of plasma glucose concentration after oral glucose challenge (mean (SD) log Lp(a) lipoprotein concentration 85 (5)) compared with subjects in the highest quintile of plasma glucose concentration (log Lp(a) lipoprotein concentration 74 (8)).
SUBJECTS WITH CORONARY ARTERY DISEASE Table III shows the characteristics of the subjects with heart disease 12 months after they had undergone coronary artery bypass surgery. Of the 245 subjects studied, 51 had impaired glucose tolerance and were matched with 51 subjects with normal glucose tolerance. The subjects with impaired glucose tolerance had significantly higher serum triglyceride concentration than the 194 subjects with normal glucose tolerance and the 51 matched controls. They also had significantly higher body mass index, higher total serum cholesterol concentration, and lower concentrations of high density lipoprotein cholesterol than the 51 matched controls. There was, however, no significant difference in the Lp(a) lipoprotein concentration and proportion of subjects with high Lp(a) lipoprotein concentrations (> 300 mg/l). Body mass index did not correlate significantly with Lp(a) lipoprotein concentration (r= -0-136, r5=0 019, p=0 345).
In the group as a whole there was no correlation between Lp(a) lipoprotein concentration and glucose tolerance (log Lp(a) lipoprotein concentration=0-003 plasma glucose concentration after oral challenge+ 2 27, r2=0 00, p=086). In contrast there were significant correlations between glucose tolerance and triglyceride concentration (log triglyceride concentration= 0-014 plasma glucose concentration+0 10, r2=0-045, p<0 0005) and high density lipoprotein cholesterol concentration (concentration = -0 017 plasma glucose concentration+1-3, r2=0-022, p<0 02). Concentrations of Lp(a) lipoprotein were no different in subjects in the lowest quintile of plasma glucose concentration after oral challenge (geometric mean (geometric SD) Lp(a) lipoprotein concentration 158 (13) mg/l) compared with subjects in the highest quintile of plasma glucose concentration (Lp(a) lipoprotein concentration 166 (11) mg/1).
LIPOPROTEIN ISOFORMS
Isoforms of Lp(a) lipoprotein were examined in the 51 subjects with heart disease who had impaired glucose tolerance and their 51 matched controls. Apart from a few subjects who had no detectable circulating isoforms ("null" phenotypes) the subjects had one or two circulating isoforms in the blood. There was no difference between the subjects with impaired glucose tolerance and their matched controls in the proportion of null, single, and double band phenotypes (single bands 71% v 57%, xI test p=O 13) . Table IV 
Discussion
A raised Lp(a) lipoprotein concentration is associated with coronary artery disease,"3' and impaired glucose tolerance has also been shown to be predictive of coronary heart disease in some studies' 2 but not in others.2526 A link has been suggested between impaired glucose tolerance and an increased circulating Lp(a) lipoprotein concentration."4 Our results do not support this report even though the asymptomatic subjects in our study were similar to those described in the earlier study (which also excluded patients with coronary artery disease). Our group of patients with coronary artery disease showed a high prevalence of impaired glucose tolerance. Our assay for Lp(a) lipoprotein was sensitive, and only 5% of results (3% of those from the patients with coronary artery disease and 8% of those from asymptomatic subjects) were below the assay's limit of detection so that real effects would not have been missed. Our results showed no relation between glucose tolerance and Lp(a) lipoprotein concentrations either in the subjects as a whole or when the subjects with impaired glucose tolerance were compared with matched individuals with normal glucose tolerance. Impaired glucose tolerance was not associated with an increase in the proportion of subjects with high Lp(a) lipoprotein concentrations (> 300 mg/l). We found no evidence of either a graded continuous effect or a threshold effect of glucose concentration after the glucose tolerance test on Lp(a) lipoprotein concentrations in either group. There were, however, significant correlations between glucose concentration after the glucose tolerance test and log triglyceride concentration and high density lipoprotein cholesterol concentration. The differences between subjects with impaired and normal glucose tolerance in their blood pressure and lipid profile were consistent with previous reports.'73' It is therefore unlikely that a real association between glucose tolerance and Lp(a) lipoprotein was missed because the populations we studied were not representative.
A genetic association between impaired glucose tolerance and diabetes mellitus in families in which non-insulin dependent diabetes mellitus occurs is well known.'3-6 If there was a genetic association between Clinical implications * High serum concentrations of Lp(a) lipoprotein and impaired glucose tolerance are both associated with coronary artery disease * It has been suggested that the association between impaired glucose tolerance and coronary artery disease may be caused by the raised Lp(a) lipoprotein concentrations * In this study of two groups, one of apparently healthy subjects and one of subjects with coronary artery disease, high Lp(a) lipoprotein concentrations and impaired glucose tolerance were associated with coronary artery disease * Neither group, however, showed a significant correlation between Lp(a) concentration and glucose tolerance, nor was there an association between impaired glucose tolerance and particular isoforms of Lp(a) 
Introduction
In recent years there has been much interest in hormone replacement therapy and the overall balance of benefits and risks.'-3 One benefit of hormone replacement therapy is its proved effect in alleviating menopausal symptoms"9-symptoms which persist for more than one year in over 80% of menopausal women.'0 Few attempts have been made to measure the impact of menopausal symptoms on quality of life or changes in quality of life resulting from use ofhormone replacement therapy. In a cost effectiveness study of hormone replacement therapy carried out in the United States, adjustments for quality of life were based on the authors' own judgments rather than on evidence." Here we report some fieldwork to assess the impact of menopausal symptoms on quality of life, involving a questionnaire based interview of 63 women aged between 45 and 60. The objective was to derive a quantitative measure of the value or "utility" placed by women on quality of life states associated with menopausal symptoms. The fieldwork was undertaken as part of a cost effectiveness study in which the outcome of hormone replacement therapy was expressed in terms of quality adjusted life years, or QALYs, an outcome measure which strives to combine the change in quality of life associated with an intervention with the change in life expectancy.
Methods
Several methods exist to measure quality of life.12 '4 We decided to use two valuation methods and to compare the results obtained from each. Firstly, subjects were given descriptions of menopausal symptoms and shown a simple visual numerical scale of 0 to 10 with defined end points of death and normal health. They were asked to pick a point on the scale that reflected the quality of life associated with the health state in question. We will refer to this as the rating scale method.
Secondly, subjects were given the same descriptions of menopausal symptoms and invited to enter a procedure for the valuation of health states known as the time trade off method, again supported by a visual illustration. This method has been applied widely in the United States for the evaluation of health states. '2 It has been argued that this method has advantages in terms of ease of application and consistency of result,'5 1 especially where the disease under investigation is chronic or does not involve life threatening
